论文部分内容阅读
小细胞肺癌(SCLC)的生物行为和临床表现与众不同,广为人知的是异位激素分泌和细胞高速率增殖。对化疗和放疗比任何肺癌都敏感。如把SCLC 当作单独一种癌,其发病率占癌症第7位,死亡占第4位。1970年前的治疗方式是手术和放疗。但Matthews 等尸检了19例死亡前30天内行根治性手术的SCLC 患者,其中60%已有确切的远处转移灶。另在一前瞻性随机分组研究中只有2%局
The biological behavior and clinical manifestations of small cell lung cancer (SCLC) are distinctive, and it is widely known that ectopic hormone secretion and high cell proliferation rate. Chemotherapy and radiotherapy are more sensitive than any lung cancer. If SCLC is treated as a single type of cancer, its incidence is 7th in cancer, and death is in 4th. The treatment before 1970 was surgery and radiotherapy. However, Matthews et al autopsied 19 SCLC patients who underwent radical surgery within the first 30 days of their death, and 60% of them had an exact distant metastasis. Another 2% in a prospective randomized study